← Back to headlines
Inhibrx director Jon Kayyem purchases over $567k in company stock
Jon Kayyem, a director at Inhibrx, executed a significant purchase of company shares worth approximately $567,580.
9 Sept, 08:31 — 9 Sept, 08:31
Sources
Showing 1 of 1 sources
